Thubeena Manickavasagar

Author

Also Known As

Archie Macnair, T Manickavasagar, T. Manickavasagar, Thubeena Manickavasagar

Publications

194

Citations

H-Index

Concepts

All Affiliations

Thubeena Manickavasagar is an author at Institute of Cancer Research specializing in molecular pharmacology, pharmacotherapy, and oncology.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	17
2	Immunology	1	1	17
3	Pharmacology	1	1	17
4	Cancer Therapeutics	1	1	17
5	Immunotherapy	1	1	17

Thubeena Manickavasagar

Publications

151

Citations

H-Index

Page 1

	Year	Citations
Vitamin <scp>D</scp> deficiency in pregnancy – still a public health issue Trixie McAree, Benjamin Jacobs, Thubeena Manickavasagar, Maternal and Child Nutrition	2012	78
53P Assessing the reporting quality of early phase dose-finding trials Christina Yap, Olga Solovyeva, Zhulin Yin, Annals of Oncology	2022	30
Phase 1 trial of the adenosine A<sub>2A</sub> receptor antagonist inupadenant (EOS-850): Update on tolerability, and antitumor activity potentially associated with the expression of the A<sub>2A</sub> receptor within the tumor. Laurence Buisseret, Sylvie Rottey, Johann S. de Bono, Journal of Clinical Oncology Antitumor ActivityImmunologyImmunoeditingPharmacotherapyImmunotherapeutics	2021	17
HER3 expression and MEK activation in non-small-cell lung carcinoma Thubeena Manickavasagar, Wei Yuan, Suzanne Carreira, Lung Cancer Management	2021	16
Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancer D.J. Hughes, Eleni Josephides, Robert O’Shea, European Radiology	2024	10

Page 1